| Literature DB >> 20954235 |
Federica Cossu1, Francesca Malvezzi, Giulia Canevari, Eloise Mastrangelo, Daniele Lecis, Domenico Delia, Pierfausto Seneci, Carlo Scolastico, Martino Bolognesi, Mario Milani.
Abstract
Inhibitor of apoptosis proteins (IAPs) are negative regulators of apoptosis. As IAPs are overexpressed in many tumors, where they confer chemoresistance, small molecules inactivating IAPs have been proposed as anticancer agents. Accordingly, a number of IAP-binding pro-apoptotic compounds that mimic the sequence corresponding to the N-terminal tetrapeptide of Smac/DIABLO, the natural endogenous IAPs inhibitor, have been developed. Here, we report the crystal structures of the BIR3 domain of cIAP1 in complex with Smac037, a Smac-mimetic known to bind potently to the XIAP-BIR3 domain and to induce degradation of cIAP1, and in complex with the novel Smac-mimetic compound Smac066. Thermal stability and fluorescence polarization assays show the stabilizing effect and the high affinity of both Smac037 and Smac066 for cIAP1- and cIAP2-BIR3 domains.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20954235 PMCID: PMC3009409 DOI: 10.1002/pro.523
Source DB: PubMed Journal: Protein Sci ISSN: 0961-8368 Impact factor: 6.725